Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of the effect of the EU’s decision to continue export controls on the Oxford/AstraZeneca vaccine produced in Halifax on the availability of the covid-19 vaccine in the UK.
UK and EU supply chains are interlinked as vaccines have complex supply chains. We are in constant contact with the vaccine manufacturers and remain confident in the continued supply of vaccine for the UK.
We have successfully met our target of offering a first vaccine dose to every person in the top four priority groups by 15 February and are on track to offer a vaccine to all priority cohorts by 15 April, as well as all adults by the end of July.